Showing results (2141-2150 of 8,898) with videos related to

Sort By:
Pageof 890
European Urology|June 10, 2022
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical TrialSimon J Crabb, Gareth Griffiths, Denise Dunkley, et al.
European Urology|January 1, 1987
Correlation between bactericidal activity of fosfomycin trometamol in an in vitro model of the urinary bladder and susceptibility testingC Pinasi, E Albini, G Marca
European Urology|January 29, 2011
Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trialRocco Damiano, Giuseppe Quarto, Ilaria Bava, et al.
European Urology|January 1, 1990
Combination studies with leuprolideE D Crawford
European Urology|February 11, 2011
The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO studyCamille P Vaughan, Theodore M Johnson, Mika A Ala-Lipasti, et al.
European Urology|February 12, 2011
A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debateCatharina A Goossens-Laan, Gea A Gooiker, Willem van Gijn, et al.
European Urology|February 8, 2011
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomyMatthias May, Edwin Herrmann, Christian Bolenz, et al.
European Urology|December 16, 2010
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al.
European Urology|January 11, 2011
Near-infrared spectroscopy: a novel, noninvasive, diagnostic method for detrusor overactivity in patients with overactive bladder symptoms--a preliminary and experimental studyFawzy F Farag, Frank M Martens, Kathleen W D'Hauwers, et al.
European Urology|December 31, 2010
Prediction of progression-free survival rates after bevacizumab plus interferon versus interferon alone in patients with metastatic renal cell carcinoma: comparison of a nomogram to the Motzer criteriaPierre I Karakiewicz, Maxine Sun, Joaquin Bellmunt, et al.
Pageof 890